SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (18120)1/25/1999 1:30:00 PM
From: DaiS  Respond to of 23519
 
RT,

I hope that EDDERD and ZEBRA can respond to this important question that you raise. Until they respond, I do not see it as a joke.

DaiS



To: RT who wrote (18120)1/25/1999 1:30:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
RT....maybe one of those 400 lb Sumo Wrestlers needs to pay you a visit.

The more reasonable answer is that Vivus is waiting to sell the Muse distribution rights for Japan to some large company like Janssen.
Once that is done the partner would apply for Japan's approval of MUSE.

PS....Muse is selling in Hong Kong, Singapore, and other countries in the far east already, and should be available in China in the second qtr 1999.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News